Motion Sickness
34
3
5
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.9%
2 terminated out of 34 trials
91.3%
+4.8% vs benchmark
35%
12 trials in Phase 3/4
24%
5 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (34)
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients
Three-Axis Wearable Adaptive Vestibular Stimulator
The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function
StableEyes With Active Neurofeedback
Nebulizer Delivery of Intranasal Scopolamine
Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation
Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot Study
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Gynecologic Endoscopic Surgery of Female Motion Sickness Patients
Motion Sickness Rehabilitation for Virtual Reality
Sensory Training for Visual Motion Sickness
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
Motion Sickness Desensitization Using VR